Live Breaking News & Updates on News Ratings For Agios Pharmaceuticals Daily

Stay updated with breaking news from News ratings for agios pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agios Pharmaceuticals (NASDAQ:AGIO) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. Several other analysts also recently weighed in on AGIO. Royal Bank of Canada reduced their target price on Agios Pharmaceuticals from $43.00 to $42.00 and set an outperform […] ....

United States , Jacqualyna Fouse , James William Burns , Frazier Life Sciences Management , Norges Bank , Goldman Sachs Group , Royal Bank , Jpmorgan Chase Co , Agios Pharmaceuticals Inc , News Ratings For Agios Pharmaceuticals Daily , Agios Pharmaceuticals Stock Down , Farallon Capital Management , Agios Pharmaceuticals , Pricet Rowe Associates Inc , Cantor Fitzgerald , Agios Pharmaceuticals Company Profile , Free Report , Pharmaceuticals Stock Down , Get Free Report , Director Jacqualyn , Capital Management , Agios Pharmaceuticals Daily ,

Leerink Partnrs Comments on Agios Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:AGIO)

Leerink Partnrs Comments on Agios Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:AGIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , James William Burns , Jacqualyna Fouse , Leerink Partnrs , Zurcher Kantonalbank Zurich Cantonalbank , Investment Management , Agios Pharmaceuticals , Cantor Fitzgerald , News Ratings For Agios Pharmaceuticals Daily , Securities Exchange Commission , Agios Pharmaceuticals Company Profile , China Universal Asset Management Co , Quest Partners , Jpmorgan Chase Co , Agios Pharmaceuticals Price Performance , Agios Pharmaceuticals Inc , Goldman Sachs Group , Royal Bank , Headlands Technologies , Free Report , Agios Pharmaceutical , Get Free Report , Exchange Commission , Director Jacqualyn , Universal Asset Management , Kantonalbank Zurich Cantonalbank ,

Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year High at $39.70

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $39.70 and last traded at $38.91, with a volume of 573087 shares changing hands. The stock had previously closed at $31.50. Wall Street Analysts Forecast Growth A number of equities analysts have recently […] ....

United States , James William Burns , Jacqualyna Fouse , News Ratings For Agios Pharmaceuticals Daily , Securities Exchange Commission , Agios Pharmaceuticals Inc , Cantor Fitzgerald , Insider Activity At Agios Pharmaceuticals , Institutional Investors Weigh In On Agios Pharmaceuticals , Farallon Capital Management , Jpmorgan Chase Co , Pricet Rowe Associates Inc , Agios Pharmaceuticals , Tidal Investments , Kennedy Capital Management , Agios Pharmaceuticals Company Profile , Goldman Sachs Group , Caxton Associates , Royal Bank , Agios Pharmaceuticals Price Performance , Get Free Report , Director Jacqualyn , Exchange Commission , Capital Management , Pricet Rowe Associates , Agios Pharmaceuticals Daily ,

Zacks Research Analysts Boost Earnings Estimates for Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Equities researchers at Zacks Research increased their Q2 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Monday, May 20th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will earn ($1.59) per share for […] ....

United States , James William Burns , Jacqualyna Fouse , Zurcher Kantonalbank Zurich Cantonalbank , Quest Partners , Cantor Fitzgerald , Goldman Sachs Group , Securities Exchange Commission , Agios Pharmaceuticals , Agios Pharmaceuticals Stock Down , China Universal Asset Management Co , Investment Management , Headlands Technologies , Jpmorgan Chase Co , News Ratings For Agios Pharmaceuticals Daily , Zacks Research , Royal Bank , Agios Pharmaceuticals Inc , Hedge Funds Weigh In On Agios Pharmaceuticals , Free Report , Agios Pharmaceutical , Pharmaceuticals Stock Down , Get Free Report , Director Jacqualyn , Exchange Commission , Universal Asset Management ,

Swiss National Bank Has $2.45 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Swiss National Bank Has $2.45 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , James William Burns , Brian Goff , Cantor Fitzgerald , Agios Pharmaceuticals Stock Performance , Exchange Commission , Swiss National Bank , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , Quarter For Agios Pharmaceuticals , China Universal Asset Management Co , News Ratings For Agios Pharmaceuticals Daily , Goldman Sachs Group , Jpmorgan Chase Co , Royal Bank , Headlands Technologies , Securities Exchange Commission , Free Report , National Bank , Universal Asset Management , Kantonalbank Zurich Cantonalbank , Teacher Retirement System , Retirement System , Get Free Report , Visit Holdingschannel ,